Present Status of Organotoxicity of Inhalation Anesthetics

  • Burnell R. BrownJr.
Conference paper
Part of the Anaesthesiologie und Intensivmedizin Anaesthesiology and Intensive Care Medicine book series (A+I, volume 185)


The introduction of halothane into clinical practice in 1958 ushered in a new era of anesthesia. This potent, nonflammable drug permitted rapid and easily controlled anesthesia depth, coupled with safe use of electrocautery by the surgeon. Perhaps the greatest boom was the quantal leap into the era of sophisticated electronic monitoring permitted by the nonflammable nature of this anesthestic. Because of space-age monitoring abilities coupled directly with increasing knowledge of physiology and pathophysiology, surgical procedures considered too dangerous and complex are now performed routinely.


Hepatic Necrosis Halothane Anesthesia Inhalation Anesthetic Reductive Pathway Halothane Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Virtue RW, Payne KW (1958) Postopertive death after fluothane. Anesthesiology 19: 562CrossRefGoogle Scholar
  2. 2.
    Vourc’h G, Schnoebelen E, Buck F, Fruhling L (1960) Hepathonephrite aigue mortelle apres anesthesie comportant de l’halothane (fluothane). Anesthes Analg (Paris) 17: 466Google Scholar
  3. 3.
    Lindenbaum J, Liefer E (1963) Hepatic necrosis associates with halothane anesthesia. N Engl J Med 268: 525PubMedCrossRefGoogle Scholar
  4. 4.
    Musher WW, Rosen M, Bowen DJ, Campbell H (1969) Halothane and liver dysfunction: a retrospective study, US Government Printing Office, WashingtonGoogle Scholar
  5. 5.
    National halothane study (1969) a study of the possible association between halothane anesthesia and postoperative hepatic necrosis. Bunker JP, Forrest WH, Mostellar T, Vandam LD (eds) US Government Printing Office, WashingtonGoogle Scholar
  6. 6.
    Inman WHW, Mushin WW (1974) Jaundice after repeated exposire to halothane: an analysis of Reports to the Committee on Safety of Medicine. Br Med J 1: 5PubMedCrossRefGoogle Scholar
  7. 7.
    Bottinger LE, Dalen E, Hallen B (1976) Halothane — induced liver damage: an analysis of the material reported to the Swedish Adverse Drug Reaction Committee. 1966–1973 Act Anesthesiol Scand 20: 40CrossRefGoogle Scholar
  8. 8.
    Moult PJA, Sherlock S (1975) Halothane related hepatitis. A clinical study of 26 cases. Q J Med 44: 99PubMedGoogle Scholar
  9. 9.
    Stier A, Alter H, Hessler V et al. (1964) Urinary excretion of bromide in halothane anesthesia. Anesth Analg (Cleve) 43: 723Google Scholar
  10. 10.
    Van Dyke RA, Chenoweth MB, Van Posnak A (1964) Metabolism of volatile anesthetics. Biochem Pharmacol 13: 1239CrossRefGoogle Scholar
  11. 11.
    Mazze RI, Shue GL, Jackson SH (1971) Renal dysfunction associated with methoxyflurane anesthesia: a randomized, prospective clinical evaluation. JAMA 216: 278PubMedCrossRefGoogle Scholar
  12. 12.
    Mazze RI, Wiidruff RT, Heerdt ME et al. (1982) Isoniazed-induced enflurane deflouridation in humans. Anesthesiology 57: 5PubMedCrossRefGoogle Scholar
  13. 13.
    Recknagel RO, Ghoshal AK (1966) Lipoperoxidation as a vector in carbon tetrachloride hepatotoxicity. Lab Invest 15: 133Google Scholar
  14. 14.
    Brown BR Jr, Sipes IG, Sagalyn AM (1974) Mechanisms of acute hepatic toxicity: chloroform halothane, and glutathione. Anesthesiology 41: 554PubMedCrossRefGoogle Scholar
  15. 15.
    Uehleke H, Hellmer KH, Tabarelli-Poplawski S (1973) Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro. Naunyn Schmiedebergs Arch Pharmacol 276L39Google Scholar
  16. 16.
    Widger LA, Gandolfi AJ, Van Dyke RA (1976) Hypoxia and halothane metabolism in vivo: release of inorganic fluoride and halothane metabolite binding to cellular constituents. Anesthesiology 44: 197PubMedCrossRefGoogle Scholar
  17. 17.
    McLain GE, Sipes IG, Brown BR Jr (1979) An animal model of halothane hepatotoxicity: rote of enzyme induction and hypoxia. Anesthesiology 51: 321PubMedCrossRefGoogle Scholar
  18. 18.
    Shingu K, Eger EI Jr, Johnson BH (1984) Hypoxia may be more important than reductive metabolism in halothane-induced hepatic injury. Anesth Analg 61: 824Google Scholar
  19. 19.
    Lunam CA (1980) Halothane hepatotoxicity in a guinea pig model. Ph. D. Dissertation. Flinders University of South AustraliaGoogle Scholar
  20. 20.
    Vergami D, Tsantoulas D, Eddleston ALWF et al. (1978) Sensitization to halothane-altered liver components in severe hepatic necrosis after halothane ansethesia. Lancet 2: 801CrossRefGoogle Scholar
  21. 21.
    Vergami D, Mieli-Gergami G, Alberti A, et al. (1980) Antibodies to rhe surface of halothane- altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 303: 66CrossRefGoogle Scholar
  22. 22.
    Kline MM (1980) Enflurane hepatitis. Gastroenterology 79: 126PubMedGoogle Scholar
  23. 23.
    Dykes MH (1984) Is enflurane hepatotoxic? (Editorial) Anesthesiology 61: 235PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Burnell R. BrownJr.

There are no affiliations available

Personalised recommendations